Unknown

Dataset Information

0

Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).


ABSTRACT: OBJECTIVE: We examined prevalence of sarcopenia in Korean patients with type 2 diabetes and compared body compositional parameters between subjects with and without type 2 diabetes. RESEARCH DESIGN AND METHODS: The Korean Sarcopenic Obesity Study (KSOS) included 810 subjects (414 patients with diabetes and 396 control subjects) who were examined using dual-energy X-ray absorptiometry. Prevalence of sarcopenia was defined using the skeletal muscle index (SMI). RESULTS: Prevalence in patients with diabetes and in the control group was 15.7 and 6.9%, respectively. In both men and women, SMI values were significantly decreased in patients with diabetes compared with subjects without diabetes. Furthermore, multiple logistic regression analysis showed that type 2 diabetes was independently associated with sarcopenia. CONCLUSIONS: Type 2 diabetes was associated with increased risk of sarcopenia. These characteristics may contribute to physical disability and metabolic disorders in older adults with diabetes.

SUBMITTER: Kim TN 

PROVIDER: S-EPMC2890348 | biostudies-other | 2010 Jul

REPOSITORIES: biostudies-other

altmetric image

Publications

Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).

Kim Tae Nyun TN   Park Man Sik MS   Yang Sae Jeong SJ   Yoo Hye Jin HJ   Kang Hyun Joo HJ   Song Wook W   Seo Ji A JA   Kim Sin Gon SG   Kim Nan Hee NH   Baik Sei Hyun SH   Choi Dong Seop DS   Choi Kyung Mook KM  

Diabetes care 20100422 7


<h4>Objective</h4>We examined prevalence of sarcopenia in Korean patients with type 2 diabetes and compared body compositional parameters between subjects with and without type 2 diabetes.<h4>Research design and methods</h4>The Korean Sarcopenic Obesity Study (KSOS) included 810 subjects (414 patients with diabetes and 396 control subjects) who were examined using dual-energy X-ray absorptiometry. Prevalence of sarcopenia was defined using the skeletal muscle index (SMI).<h4>Results</h4>Prevalen  ...[more]

Similar Datasets

| S-EPMC4188124 | biostudies-literature
| S-EPMC6502449 | biostudies-literature
| S-EPMC5861907 | biostudies-literature
| S-EPMC9329691 | biostudies-literature
| S-EPMC8584842 | biostudies-literature
| S-EPMC7686337 | biostudies-literature
| S-EPMC5877684 | biostudies-other
| S-EPMC8414692 | biostudies-literature
| S-EPMC7477770 | biostudies-literature
| S-EPMC5525561 | biostudies-other